| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 31.268 | 46.911 | 55.031 | 51.143 | 54.336 | 54.219 |
| Total Income - EUR | - | - | - | - | 31.268 | 46.911 | 55.031 | 51.143 | 54.336 | 54.222 |
| Total Expenses - EUR | - | - | - | - | 27.914 | 45.535 | 49.637 | 47.823 | 51.364 | 46.183 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.354 | 1.375 | 5.394 | 3.320 | 2.973 | 8.039 |
| Net Profit/Loss - EUR | - | - | - | - | 3.041 | 1.045 | 5.028 | 2.886 | 2.511 | 6.720 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Biokert S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 28 | 0 | 0 | 20 | 0 | 0 |
| Current Assets | - | - | - | - | 7.257 | 16.800 | 16.965 | 22.479 | 29.291 | 33.939 |
| Inventories | - | - | - | - | 1.880 | 13.849 | 16.524 | 21.576 | 28.240 | 31.360 |
| Receivables | - | - | - | - | 1.357 | 1.607 | 354 | 355 | 68 | 123 |
| Cash | - | - | - | - | 4.020 | 1.344 | 88 | 549 | 984 | 2.456 |
| Shareholders Funds | - | - | - | - | 3.083 | 4.070 | 9.008 | 11.921 | 14.396 | 17.075 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 4.202 | 12.729 | 7.957 | 10.578 | 14.895 | 16.864 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Biokert S.r.l.